Works by Kurzrock, Razelle

Results: 343

The prognostic significance of cytokine levels in newly diagnosed acute myeloid leukemia and high-risk myelodysplastic syndromes.

Published in:

2008

By:

Tsimberidou, Apóstolia Maria;
Estey, Elihu;
Sijin Wen;
Pierce, Sherry;
Kantarjian, Hagop;
Albitar, Maher;
Kurzrock, Razellé;
Tsimberidou, Apostolia Maria;
Wen, Sijin;
Kurzrock, Razelle

Publication type:

journal article

Molecular Testing and Targeted Therapies in Hepatobiliary Cancers: A Review.

Published in:

JAMA Surgery, 2025, v. 160, n. 5, p. 576, doi. 10.1001/jamasurg.2025.0242

By:

Tsilimigras, Diamantis I.;
Kurzrock, Razelle;
Pawlik, Timothy M.

Publication type:

Article

Patient rights in precision oncology: right treatment, right time, right dose, right order, right place.

Published in:

Genome Medicine, 2025, v. 17, n. 1, p. 1, doi. 10.1186/s13073-025-01468-y

By:

Fountzilas, Elena;
Tsimberidou, Apostolia-Maria;
Kurzrock, Razelle

Publication type:

Article

Novel clinical trial designs emerging from the molecular reclassification of cancer.

Published in:

CA: A Cancer Journal for Clinicians, 2025, v. 75, n. 3, p. 243, doi. 10.3322/caac.21880

By:

Nikanjam, Mina;
Kato, Shumei;
Allen, Teresa;
Sicklick, Jason K.;
Kurzrock, Razelle

Publication type:

Article

How to detect skin signs of malignancy.

Published in:

Patient Care (Print), 2002, v. 36, n. 5, p. 21

By:

Cohen, Philip R.;
Kurzrock, Razelle

Publication type:

Article

Pharmacokinetics and antitumor activity of patupilone combined with midazolam or omeprazole in patients with advanced cancer.

Published in:

Cancer Chemotherapy & Pharmacology, 2011, v. 68, n. 6, p. 1507, doi. 10.1007/s00280-011-1635-7

By:

Tsimberidou, Apostolia-Maria;
Lewis, Nancy;
Reid, Tony;
Burris, Howard;
Urban, Patrick;
Tan, Eugene;
Anand, Suraj;
Uehara, Cynthia;
Kurzrock, Razelle

Publication type:

Article

Phase I clinical trial of hepatic arterial infusion of paclitaxel in patients with advanced cancer and dominant liver involvement.

Published in:

Cancer Chemotherapy & Pharmacology, 2011, v. 68, n. 1, p. 247, doi. 10.1007/s00280-010-1482-y

By:

Tsimberidou, Apostolia;
Letourneau, Katherine;
Fu, Siqing;
Hong, David;
Naing, Aung;
Wheler, Jennifer;
Uehara, Cynthia;
McRae, Stephen;
Wen, Sijin;
Kurzrock, Razelle

Publication type:

Article

Phase I clinical trial of hepatic arterial infusion of cisplatin in combination with intravenous liposomal doxorubicin in patients with advanced cancer and dominant liver involvement.

Published in:

Cancer Chemotherapy & Pharmacology, 2010, v. 66, n. 6, p. 1087, doi. 10.1007/s00280-010-1266-4

By:

Tsimberidou, Apostolia M.;
Moulder, Stacy;
Siqing Fu;
Sijin Wen;
Aung Naing;
Bedikian, Agop Y.;
Daring, Shawn;
Uehara, Cynthia;
Chaan Ng;
Wallace, Michael;
Camacho, Luis;
Kurzrock, Razelle

Publication type:

Article

Phase 1 first-in-human clinical study of S- trans, trans-farnesylthiosalicylic acid (salirasib) in patients with solid tumors.

Published in:

Cancer Chemotherapy & Pharmacology, 2010, v. 65, n. 2, p. 235, doi. 10.1007/s00280-009-1027-4

By:

Tsimberidou, Apostolia Maria;
Rudek, Michelle A.;
Hong, David;
Ng, Chaan S.;
Blair, Jessica;
Goldsweig, Howard;
Kurzrock, Razelle

Publication type:

Article

Recombinant human soluble tumor necrosis factor (TNF) receptor (p75) fusion protein Enbrel in patients with refractory hematologic malignancies.

Published in:

Cancer Chemotherapy & Pharmacology, 2002, v. 50, n. 3, p. 237, doi. 10.1007/s00280-002-0479-6

By:

Tsimberidou, Apostolia-Maria;
Thomas, Deborah;
O'Brien, Susan;
Andreeff, Michael;
Kurzrock, Razelle;
Keating, Michael;
Albitar, Maher;
Kantarjian, Hagop;
Giles, Francis

Publication type:

Article

Pharmacokinetics, Single-Dose Tolerance, and Biological Activity of Recombinant Gamma-Interferon in Cancer Patients.

Published in:

Oncology, 1985, v. 42, n. S1, p. 41, doi. 10.1159/000226083

By:

Kurzrock, Razelle;
Rosenblum, Michael G.;
Sherwin, Stephen A.;
Rios, Adan;
Talpaz, Moshe;
Quesada, Jorge R.;
Gutterman, Jordan U.

Publication type:

Article

Home-run trials for rare cancers: giving the right drug(s) to the right patients at the right time and in the right place.

Published in:

NPJ Precision Oncology, 2023, v. 7, n. 1, p. 1, doi. 10.1038/s41698-023-00487-5

By:

Adashek, Jacob J.;
Kurzrock, Razelle

Publication type:

Article

ALK fusions in the pan-cancer setting: another tumor-agnostic target?

Published in:

NPJ Precision Oncology, 2023, v. 7, n. 1, p. 1, doi. 10.1038/s41698-023-00449-x

By:

Shreenivas, Aditya;
Janku, Filip;
Gouda, Mohamed A.;
Chen, Hui-Zi;
George, Ben;
Kato, Shumei;
Kurzrock, Razelle

Publication type:

Article

ALK fusions in the pan-cancer setting: another tumor-agnostic target?

Published in:

NPJ Precision Oncology, 2023, v. 7, n. 1, p. 1, doi. 10.1038/s41698-023-00449-x

By:

Shreenivas, Aditya;
Janku, Filip;
Gouda, Mohamed A.;
Chen, Hui-Zi;
George, Ben;
Kato, Shumei;
Kurzrock, Razelle

Publication type:

Article

Pan-cancer molecular tumor board experience with biomarker-driven precision immunotherapy.

Published in:

NPJ Precision Oncology, 2022, v. 6, n. 1, p. 1, doi. 10.1038/s41698-022-00309-0

By:

Louie, Bryan H.;
Kato, Shumei;
Kim, Ki Hwan;
Lim, Hyo Jeong;
Okamura, Ryosuke;
Eskander, Ramez N.;
Botta, Gregory;
Patel, Hitendra;
Lee, Suzanna;
Lippman, Scott M.;
Sicklick, Jason K.;
Kurzrock, Razelle

Publication type:

Article

Case series of outcomes in advanced cancer patients with single pathway alterations receiving N-of-One therapies.

Published in:

NPJ Precision Oncology, 2022, v. 6, n. 1, p. 1, doi. 10.1038/s41698-022-00259-7

By:

Gupta, Diviya;
Kurzrock, Razelle;
Lee, Suzanna;
Okamura, Ryosuke;
Lim, Hyo Jeong;
Kim, Ki Hwan;
Sicklick, Jason K.;
Kato, Shumei

Publication type:

Article

Dual EGFR blockade with cetuximab and erlotinib combined with anti-VEGF antibody bevacizumab in advanced solid tumors: a phase 1 dose escalation triplet combination trial.

Published in:

Experimental Hematology & Oncology, 2020, v. 9, n. 1, p. 1, doi. 10.1186/s40164-020-00159-1

By:

Subbiah, Vivek;
Dumbrava, Ecaterina Ileana;
Jiang, Yunfang;
Thein, Kyaw Z.;
Naing, Aung;
Hong, David S.;
Fu, Siqing;
Piha-Paul, Sarina A.;
Tsimberidou, Apostolia M.;
Janku, Filip;
Meric-Bernstam, Funda;
Kurzrock, Razelle;
Falchook, Gerald

Publication type:

Article

Risks and Benefits of Phase 1 Oncology Trials, Revisited

Published in:

Apollo Medicine, 2008, v. 5, n. 3, p. 259, doi. 10.1177/0976001620080328

By:

Kurzrock, Razelle;
Benjamin, Robert S

Publication type:

Article

Relationship between tumor mutational burden and maximum standardized uptake value in 2-[18F]FDG PET (positron emission tomography) scan in cancer patients.

Published in:

EJNMMI Research, 2020, v. 10, n. 1, p. 1, doi. 10.1186/s13550-020-00732-z

By:

Haghighat Jahromi, Amin;
Barkauskas, Donald A.;
Zabel, Matthew;
Goodman, Aaron M.;
Frampton, Garret;
Nikanjam, Mina;
Hoh, Carl K.;
Kurzrock, Razelle

Publication type:

Article

BRAF Inhibitor Dabrafenib in Patients with Metastatic BRAF-Mutant Thyroid Cancer.

Published in:

Thyroid, 2015, v. 25, n. 1, p. 71, doi. 10.1089/thy.2014.0123

By:

Falchook, Gerald S.;
Millward, Michael;
Hong, David;
Naing, Aung;
Piha-Paul, Sarina;
Waguespack, Steven G.;
Cabanillas, Maria E.;
Sherman, Steven I.;
Ma, Bo;
Curtis, Martin;
Goodman, Vicki;
Kurzrock, Razelle

Publication type:

Article

Outcome differences by sex in oncology clinical trials.

Published in:

Nature Communications, 2024, v. 15, n. 1, p. 1, doi. 10.1038/s41467-024-46945-x

By:

Kammula, Ashwin V.;
Schäffer, Alejandro A.;
Rajagopal, Padma Sheila;
Kurzrock, Razelle;
Ruppin, Eytan

Publication type:

Article

Overcoming Immune Checkpoint Therapy Resistance with SHP2 Inhibition in Cancer and Immune Cells: A Review of the Literature and Novel Combinatorial Approaches.

Published in:

Cancers, 2023, v. 15, n. 22, p. 5384, doi. 10.3390/cancers15225384

By:

Tojjari, Alireza;
Saeed, Anwaar;
Sadeghipour, Arezoo;
Kurzrock, Razelle;
Cavalcante, Ludimila

Publication type:

Article

Evolution of the Targeted Therapy Landscape for Cholangiocarcinoma: Is Cholangiocarcinoma the 'NSCLC' of GI Oncology?

Published in:

Cancers, 2023, v. 15, n. 5, p. 1578, doi. 10.3390/cancers15051578

By:

Gupta, Amol;
Kurzrock, Razelle;
Adashek, Jacob J.

Publication type:

Article

Prevalence of ARID1A Mutations in Cell-Free Circulating Tumor DNA in a Cohort of 71,301 Patients and Association with Driver Co-Alterations.

Published in:

Cancers, 2022, v. 14, n. 17, p. 4281, doi. 10.3390/cancers14174281

By:

Kurzrock, Razelle;
Aggarwal, Charu;
Weipert, Caroline;
Kiedrowski, Lesli;
Riess, Jonathan;
Lenz, Heinz-Josef;
Gandara, David

Publication type:

Article

Cancer-of-Unknown-Primary-Origin: A SEER–Medicare Study of Patterns of Care and Outcomes among Elderly Patients in Clinical Practice.

Published in:

Cancers, 2022, v. 14, n. 12, p. 2905, doi. 10.3390/cancers14122905

By:

Mileshkin, Linda;
Bochtler, Tilmann;
Gatta, Gemma;
Kurzrock, Razelle;
Beringer, Andreas;
Müller-Ohldach, Mathis;
Surinach, Andy;
Perret, Camille;
Thomas, Marlene;
Gondos, Adam;
Krämer, Alwin

Publication type:

Article

Signed in Blood: Circulating Tumor DNA in Cancer Diagnosis, Treatment and Screening.

Published in:

Cancers, 2021, v. 13, n. 14, p. 3600, doi. 10.3390/cancers13143600

By:

Adashek, Jacob J.;
Janku, Filip;
Kurzrock, Razelle

Publication type:

Article

Circulating Tumor Cells: From the Laboratory to the Cancer Clinic.

Published in:

Cancers, 2020, v. 12, n. 9, p. 2361, doi. 10.3390/cancers12092361

By:

Agashe, Ruchi;
Kurzrock, Razelle

Publication type:

Article

IGF-1R/mTOR Targeted Therapy for Ewing Sarcoma: A Meta-Analysis of Five IGF-1R-Related Trials Matched to Proteomic and Radiologic Predictive Biomarkers.

Published in:

Cancers, 2020, v. 12, n. 7, p. 1768, doi. 10.3390/cancers12071768

By:

Amin, Hesham M.;
Morani, Ajaykumar C.;
Daw, Najat C.;
Lamhamedi-Cherradi, Salah-Eddine;
Subbiah, Vivek;
Menegaz, Brian A.;
Vishwamitra, Deeksha;
Eskandari, Ghazaleh;
George, Bhawana;
Benjamin, Robert S.;
Patel, Shreyaskumar;
Song, Juhee;
Lazar, Alexander J.;
Wang, Wei-Lien;
Kurzrock, Razelle;
Pappo, Alberto;
Anderson, Peter M.;
Schwartz, Gary K.;
Araujo, Dejka;
Cuglievan, Branko

Publication type:

Article

The Crossroads of Precision Medicine and Therapeutic Decision-Making: Use of an Analytical Computational Platform to Predict Response to Cancer Treatments.

Published in:

Cancers, 2020, v. 12, n. 1, p. 166, doi. 10.3390/cancers12010166

By:

Boichard, Amélie;
Richard, Stephane B.;
Kurzrock, Razelle

Publication type:

Article

Liquid biopsy: current technology and clinical applications.

Published in:

Journal of Hematology & Oncology, 2022, v. 15, n. 1, p. 1, doi. 10.1186/s13045-022-01351-y

By:

Nikanjam, Mina;
Kato, Shumei;
Kurzrock, Razelle

Publication type:

Article

Osteosarcoma with cell-cycle and fibroblast growth factor genomic alterations: case report of Molecular Tumor Board combination strategy resulting in long-term exceptional response.

Published in:

2022

By:

Persha, Hanna E.;
Kato, Shumei;
De, Pradip;
Adashek, Jacob J.;
Sicklick, Jason K.;
Subbiah, Vivek;
Kurzrock, Razelle

Publication type:

Case Study

Therapeutic implications of cancer gene amplifications without mRNA overexpression: silence may not be golden.

Published in:

Journal of Hematology & Oncology, 2021, v. 14, n. 1, p. 1, doi. 10.1186/s13045-021-01211-1

By:

Boichard, Amélie;
Lippman, Scott M.;
Kurzrock, Razelle

Publication type:

Article

High tumor amplification burden is associated with TP53 mutations in the pan-cancer setting.

Published in:

Cancer Biology & Therapy, 2022, v. 23, n. 1, p. 1, doi. 10.1080/15384047.2022.2128608

By:

Joshi, Rushikesh S.;
Boichard, Amelie;
Adashek, Jacob J.;
Kurzrock, Razelle

Publication type:

Article

Standardized uptake value (SUV<sub>max</sub>) in <sup>18</sup>F-FDG PET/CT is correlated with the total number of main oncogenic anomalies in cancer patients.

Published in:

Cancer Biology & Therapy, 2020, v. 21, n. 11, p. 1067, doi. 10.1080/15384047.2020.1834793

By:

Haghighat Jahromi, Amin;
Chang, Geraldine;
Kurzrock, Razelle;
Hoh, Carl K.

Publication type:

Article

Mutated TP53 is a marker of increased VEGF expression: analysis of 7,525 pan-cancer tissues.

Published in:

Cancer Biology & Therapy, 2020, v. 21, n. 1, p. 95, doi. 10.1080/15384047.2019.1665956

By:

Li, Alex M.;
Boichard, Amélie;
Kurzrock, Razelle

Publication type:

Article

Successful implementation of genomically based treatment of chemotherapy refractory peripheral T-cell lymphoma (PTCL).

Published in:

Cancer Biology & Therapy, 2019, v. 20, n. 3, p. 247, doi. 10.1080/15384047.2018.1523857

By:

Galanina, Natalie;
Kurzrock, Razelle

Publication type:

Article

Next-generation sequencing of prostate cancer: genomic and pathway alterations, potential actionability patterns, and relative rate of use of clinical-grade testing.

Published in:

Cancer Biology & Therapy, 2019, v. 20, n. 2, p. 219, doi. 10.1080/15384047.2018.1523849

By:

Ikeda, Sadakatsu;
Elkin, Sheryl K.;
Tomson, Brett N.;
Carter, Jennifer L.;
Kurzrock, Razelle

Publication type:

Article

JAK2 V617F mutation in plasma cell-free DNA preceding clinically overt myelofibrosis: Implications for early diagnosis.

Published in:

Cancer Biology & Therapy, 2018, v. 19, n. 8, p. 664, doi. 10.1080/15384047.2018.1450120

By:

Choi, Michael Y.;
Kato, Shumei;
Wang, Huan-You;
Lin, Jonathan H.;
Lanman, Richard B.;
Kurzrock, Razelle

Publication type:

Article

BRAF mutation as a novel driver of eosinophilic cystitis.

Published in:

Cancer Biology & Therapy, 2017, v. 18, n. 9, p. 655, doi. 10.1080/15384047.2017.1360449

By:

Choi, Michael Y.;
Tsigelny, Igor F.;
Boichard, Amelie;
Skjevik, Åge A.;
Shabaik, Ahmed;
Kurzrock, Razelle

Publication type:

Article

Multi‐omic analysis in carcinoma of unknown primary (CUP): therapeutic impact of knowing the unknown.

Published in:

Molecular Oncology, 2024, v. 18, n. 4, p. 956, doi. 10.1002/1878-0261.13293

By:

Kato, Shumei;
Gumas, Sophia;
Adashek, Jacob J.;
Okamura, Ryosuke;
Lee, Suzanna;
Sicklick, Jason K.;
Kurzrock, Razelle

Publication type:

Article

Multi‐omic analysis in carcinoma of unknown primary (CUP): therapeutic impact of knowing the unknown.

Published in:

Molecular Oncology, 2024, v. 18, n. 4, p. 956, doi. 10.1002/1878-0261.13293

By:

Kato, Shumei;
Gumas, Sophia;
Adashek, Jacob J.;
Okamura, Ryosuke;
Lee, Suzanna;
Sicklick, Jason K.;
Kurzrock, Razelle

Publication type:

Article

Concordance between cancer gene alterations in tumor and circulating tumor DNA correlates with poor survival in a real‐world precision‐medicine population.

Published in:

Molecular Oncology, 2023, v. 17, n. 9, p. 1844, doi. 10.1002/1878-0261.13383

By:

Rosenberg, Shai;
Ben Cohen, Gil;
Kato, Shumei;
Okamura, Ryosuke;
Lippman, Scott M.;
Kurzrock, Razelle

Publication type:

Article

Precision medicine-based therapies in advanced colorectal cancer: The University of California San Diego Molecular Tumor Board experience.

Published in:

Molecular Oncology, 2022, v. 16, n. 13, p. 2575, doi. 10.1002/1878-0261.13202

By:

Louie, Bryan H.;
Shumei Kato;
Ki Hwan Kim;
Hyo Jeong Lim;
Lee, Suzanna;
Ryosuke Okamura;
Fanta, Paul T.;
Kurzrock, Razelle

Publication type:

Article

Clinical implications of plasma circulating tumor DNA in gynecologic cancer patients.

Published in:

Molecular Oncology, 2021, v. 15, n. 1, p. 67, doi. 10.1002/1878-0261.12791

By:

Charo, Lindsey M.;
Eskander, Ramez N.;
Okamura, Ryosuke;
Patel, Sandip P.;
Nikanjam, Mina;
Lanman, Richard B.;
Piccioni, David E.;
Kato, Shumei;
McHale, Michael T.;
Kurzrock, Razelle

Publication type:

Article

Role of ultraviolet mutational signature versus tumor mutation burden in predicting response to immunotherapy.

Published in:

Molecular Oncology, 2020, v. 14, n. 8, p. 1680, doi. 10.1002/1878-0261.12748

By:

Pham, Timothy V.;
Boichard, Amélie;
Goodman, Aaron;
Riviere, Paul;
Yeerna, Huwate;
Tamayo, Pablo;
Kurzrock, Razelle

Publication type:

Article

Concordance between TP53 alterations in blood and tissue: impact of time interval, biopsy site, cancer type and circulating tumor DNA burden.

Published in:

Molecular Oncology, 2020, v. 14, n. 6, p. 1242, doi. 10.1002/1878-0261.12672

By:

Bieg‐Bourne, Cheyennedra C.;
Okamura, Ryosuke;
Kurzrock, Razelle

Publication type:

Article

Epidermal growth factor receptor mutation and diverse tumors: Case report and concise literature review

Published in:

Molecular Oncology, 2010, v. 4, n. 4, p. 306, doi. 10.1016/j.molonc.2010.03.002

By:

Chintala, Lakshmi;
Kurzrock, Razelle

Publication type:

Article

Phase I/II sequencing study of azacitidine, epacadostat, and pembrolizumab in advanced solid tumors.

Published in:

British Journal of Cancer, 2023, v. 128, n. 12, p. 2227, doi. 10.1038/s41416-023-02267-1

By:

Luke, Jason J.;
Fakih, Marwan;
Schneider, Charles;
Chiorean, E. Gabriela;
Bendell, Johanna;
Kristeleit, Rebecca;
Kurzrock, Razelle;
Blagden, Sarah P.;
Brana, Irene;
Goff, Laura W.;
O'Hayer, Kevin;
Geschwindt, Ryan;
Smith, Michael;
Zhou, Feng;
Naing, Aung

Publication type:

Article

Phase I study of nab-paclitaxel, gemcitabine, and bevacizumab in patients with advanced cancers.

Published in:

2018

By:

Sen, Shiraj;
Kato, Shumei;
Agarwal, Rishi;
Piha-Paul, Sarina;
Hess, Kenneth;
Karp, Daniel;
Janku, Filip;
Fu, Siqing;
Naing, Aung;
Pant, Shubham;
Falchook, Gerald;
Tang, Chad;
Wu, Xifeng;
Ye, Yuanqing;
Tsimberidou, Apostolia;
Subbiah, Vivek;
Kurzrock, Razelle;
Byers, Lauren;
Westin, Shannon;
Lim, JoAnn

Publication type:

journal article

Clinical pharmacodynamic/exposure characterisation of the multikinase inhibitor ilorasertib (ABT-348) in a phase 1 dose-escalation trial.

Published in:

2018

By:

Maitland, Michael L.;
Piha-Paul, Sarina;
Falchook, Gerald;
Kurzrock, Razelle;
Nguyen, Ly;
Janisch, Linda;
Karovic, Sanja;
McKee, Mark;
Hoening, Elizabeth;
Wong, Shekman;
Munasinghe, Wijith;
Palma, Joann;
Donawho, Cherrie;
Lian, Guinan K.;
Ansell, Peter;
Ratain, Mark J.;
Hong, David

Publication type:

journal article